CR
Columbia River Financial Group, LLC
13F filer · CIK 0002057074Reported Aug 13, 2026
Net seller this quarter
13F portfolio value$186MU.S. long equity reported on 13F
Positions141 new · 1 closed
Net flow last quarter-$4.83MBuys minus sells
Top 10 positions weight17.8%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Aug 13, 202614 positions | |||||
| $12.2M | 6.58% | 1.65% | +9.6% | Q4 2024 | |
| $8.01M | 4.30% | Not reported | -40.7% | Q4 2024 | |
| $3.75M | 2.01% | Not reported | -2.0% | Q4 2024 | |
| $2.28M | 1.22% | 0.00% | Not reported | Q4 2024 | |
| $1.75M | 0.94% | 0.00% | Not reported | Q4 2024 | |
| $1.45M | 0.78% | 0.00% | -1.9% | Q4 2024 | |
| $1.16M | 0.62% | Not reported | -1.1% | Q4 2024 | |
| $935K | 0.50% | 0.00% | Not reported | Q1 2025 | |
| $827K | 0.44% | 0.00% | -2.1% | Q4 2024 | |
| $809K | 0.43% | 0.00% | Not reported | Q4 2024 | |
| $589K | 0.32% | 0.00% | Not reported | Q4 2024 | |
| $352K | 0.19% | 0.05% | Not reported | Q1 2026 | |
| $320K | 0.17% | 0.00% | Not reported | Q4 2024 | |
| $292K | 0.16% | 0.00% | Not reported | Q1 2025 | |
| Q1 2026Reported May 12, 202614 positions | |||||
| $13.5M | 7.87% | Not reported | +5.1% | Q4 2024 | |
| $11.2M | 6.53% | 1.51% | +5.4% | Q4 2024 | |
| $3M | 1.74% | Not reported | +4.1% | Q4 2024 | |
| $1.99M | 1.16% | 0.00% | +4.1% | Q4 2024 | |
| $1.56M | 0.91% | 0.00% | Not reported | Q4 2024 | |
| $1.47M | 0.85% | 0.00% | -1.3% | Q4 2024 | |
| $1.1M | 0.64% | Not reported | -0.8% | Q4 2024 | |
| $1M | 0.58% | 0.00% | Not reported | Q4 2024 | |
| $876K | 0.51% | 0.00% | Not reported | Q1 2025 | |
| $741K | 0.43% | 0.00% | +49.4% | Q4 2024 | |
| $554K | 0.32% | 0.00% | Not reported | Q4 2024 | |
| $268K | 0.16% | 0.04% | New | Q1 2026 | |
| $245K | 0.14% | 0.00% | Not reported | Q4 2024 | |
| $221K | 0.13% | 0.00% | Not reported | Q1 2025 | |
| Q4 2025Reported Feb 12, 202612 positions | |||||
| $13M | 7.95% | Not reported | +9.6% | Q4 2024 | |
| $10.7M | 6.58% | 1.44% | +13.1% | Q4 2024 | |
| $3.07M | 1.88% | Not reported | -10.9% | Q4 2024 | |
| $2.12M | 1.30% | 0.00% | Not reported | Q4 2024 | |
| $1.94M | 1.19% | 0.00% | +0.2% | Q4 2024 | |
| $1.49M | 0.91% | 0.00% | Not reported | Q4 2024 | |
| $1.07M | 0.66% | Not reported | -1.5% | Q4 2024 | |
| $712K | 0.44% | 0.00% | +1.8% | Q4 2024 | |
| $531K | 0.33% | 0.00% | Not reported | Q4 2024 | |
| $501K | 0.31% | 0.00% | Not reported | Q4 2024 | |
| $287K | 0.18% | 0.00% | Not reported | Q4 2024 | |
| PBPMBSPuramed Bioscience Inc. | $245K | 0.15% | 0.00% | New | Q4 2025 |
| Q3 2025Reported Nov 14, 202511 positions | |||||
| $11.9M | 7.32% | Not reported | +2.7% | Q4 2024 | |
| $9.48M | 5.85% | 1.27% | +4.2% | Q4 2024 | |
| $3.49M | 2.15% | Not reported | -3.4% | Q4 2024 | |
| $2.28M | 1.41% | 0.00% | Not reported | Q4 2024 | |
| $2.03M | 1.25% | 0.00% | Not reported | Q4 2024 | |
| $1.44M | 0.89% | 0.00% | Not reported | Q4 2024 | |
| $1.07M | 0.66% | Not reported | +0.6% | Q4 2024 | |
| $687K | 0.42% | 0.00% | -0.5% | Q4 2024 | |
| $526K | 0.32% | 0.00% | -1.5% | Q4 2024 | |
| $516K | 0.32% | 0.00% | Not reported | Q4 2024 | |
| $258K | 0.16% | 0.00% | Not reported | Q4 2024 | |
Premium opens every quarter this fund has filed